Comments on the Food and Drug Administration (FDA) Cardiac and Renal Drugs Advisory Committee Recommended Guidelines for the Conduct of Antianginal Drug Trials
Keyword(s):
2021 ◽
Vol 10
(3)
◽
pp. 122-122
1970 ◽
Vol 16
(1)
◽
pp. 264-296
◽
2014 ◽
Vol 130
(15)
◽
pp. 1287-1294
◽
Keyword(s):